Suppr超能文献

普瑞巴林与地塞米松对鼻中隔成形术后镇痛的影响。

Effect of pregabalin and dexamethasone on postoperative analgesia after septoplasty.

作者信息

Demirhan Abdullah, Akkaya Akcan, Tekelioglu Umit Yasar, Apuhan Tayfun, Bilgi Murat, Yurttas Veysel, Bayir Hakan, Yildiz Isa, Gok Uzeyir, Kocoglu Hasan

机构信息

Department of Anesthesiology and Reanimation, Faculty of Medicine, Abant Izzet Baysal University, Golkoy, 14280 Bolu, Turkey.

Department of Otorhinolaryngology, Faculty of Medicine, Abant Izzet Baysal University, Golkoy, 14280 Bolu, Turkey.

出版信息

Pain Res Treat. 2014;2014:850794. doi: 10.1155/2014/850794. Epub 2014 Apr 24.

Abstract

Objectives. The aim of this study was to explore effect of a combination of pregabalin and dexamethasone on pain control after septoplasty operations. Methods. In this study, 90 patients who were scheduled for septoplasty under general anesthesia were randomly assigned into groups that received either placebo (Group C), pregabalin (Group P), or pregabalin and dexamethasone (Group PD). Preoperatively, patients received either pregabalin 300 mg one hour before surgery, dexamethasone 8 mg intravenously during induction, or placebo according to their allocation. Postoperative pain treatment included tramadol and diclofenac sodium 30 minutes before the end of the operation. Numeric rating scale (NRS) for pain assessment, side effects, and consumption of tramadol, pethidine, and ondansetron were recorded. Results. The median NRS score at the postoperative 0 and the 2nd h was significantly higher in Group C than in Group P and Group PD (P ≤ 0.004 for both). The 24 h tramadol and pethidine, consumptions were significantly reduced in Groups P and PD compared to Group C (P < 0.001 and P < 0.001). The incidence of blurred vision was significantly higher in Group PD compared to Group C within both 0-2 h and 0-24 h periods (P = 0.002 and P < 0.001, resp.). Conclusions. We conclude that administration of 300 mg pregabalin preoperatively may be an adequate choice for pain control after septoplasty. Addition of dexamethasone does not significantly reduce pain in these patients.

摘要

目的。本研究旨在探讨普瑞巴林与地塞米松联合用药对鼻中隔成形术后疼痛控制的效果。方法。在本研究中,90例计划在全身麻醉下进行鼻中隔成形术的患者被随机分为接受安慰剂的组(C组)、普瑞巴林组(P组)或普瑞巴林与地塞米松组(PD组)。术前,患者根据分组在手术前1小时接受300毫克普瑞巴林、诱导期间静脉注射8毫克地塞米松或安慰剂。术后疼痛治疗包括在手术结束前30分钟使用曲马多和双氯芬酸钠。记录疼痛评估的数字评分量表(NRS)、副作用以及曲马多、哌替啶和昂丹司琼的使用情况。结果。术后0小时和2小时时,C组的NRS评分中位数显著高于P组和PD组(两者均P≤0.004)。与C组相比,P组和PD组的24小时曲马多和哌替啶使用量显著减少(P<0.001和P<0.001)。在0 - 2小时和0 - 24小时期间,PD组的视力模糊发生率均显著高于C组(分别为P = 0.002和P<0.001)。结论。我们得出结论,术前给予300毫克普瑞巴林可能是鼻中隔成形术后疼痛控制的合适选择。添加地塞米松并不能显著减轻这些患者的疼痛。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/690d/4020296/bfb9ee1c6682/PRT2014-850794.001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验